Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01959321 · ClinicalTrials.gov registry record

An Observational Study of Hepatitis C Virus in Pregnancy

A clinical trial of Hepatitis C, sponsored by The George Washington University Biostatistics Center.

Completed
Registry status
772
Enrollment target
17
Study locations

NCT01959321 is a study of Hepatitis C that has completed, run by The George Washington University Biostatistics Center. The registered enrollment target is 772 participants, below the 1,883-participant average among 106 other Hepatitis C trials with a reported enrollment target (59% lower). The trial reports 17 study locations across 12 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01959321, a study of Hepatitis C, has completed, sponsored by The George Washington University Biostatistics Center.

COMPLETED
Registry status
772 participants
Enrollment target
17
Study locations

Study Summary

This multi-center observational study examines risk factors for HCV transmission from mother to baby.

Conditions Studied

Study Locations (17)

Texas

  • University of Texas Southwestern Medical Center - Dallas
  • University of Texas - Galveston - Galveston
  • University of Texas - Houston - Houston

North Carolina

  • University of North Carolina - Chapel Hill - Chapel Hill
  • Duke University - Durham

Ohio

  • Case Western Reserve University - Cleveland
  • Ohio State University - Columbus

Pennsylvania

  • University of Pennsylvania - Philadelphia
  • Magee Women's Hospital of UPMC - Pittsburgh

Alabama

  • University of Alabama - Birmingham - Birmingham

California

  • Stanford University - Stanford

Colorado

  • University of Colorado - Denver

Illinois

  • Northwestern University - Chicago

Trial Details

FieldValue
Enrollment Target 772 participants
Start Date 2012-10
Est. Completion 2021-06-30

What the Registry Record Tells You About NCT01959321

The ClinicalTrials.gov registry entry for NCT01959321 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 772 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,883-participant average among 106 other Hepatitis C trials with a reported enrollment target (59% lower). The listed sponsor is The George Washington University Biostatistics Center, which has 24 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hepatitis C appearing as the primary indexed condition, and to 0 interventions.

NCT01959321 reports 17 study locations spanning 12 distinct geographic areas - top geographies include Texas, North Carolina, Ohio.

Frequently Asked Questions

What is clinical trial NCT01959321 about?

NCT01959321 is a clinical study titled "An Observational Study of Hepatitis C Virus in Pregnancy". This multi-center observational study examines risk factors for HCV transmission from mother to baby.

What is the current status of trial NCT01959321?

This trial is currently completed. The enrollment target is 772 participants. The study started on 2012-10. Estimated completion is 2021-06-30.

What conditions does trial NCT01959321 study?

This clinical trial studies the following conditions: Hepatitis C.

Who is sponsoring clinical trial NCT01959321?

This trial is sponsored by The George Washington University Biostatistics Center, which has 24 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01959321 being conducted?

This trial has 17 study locations across Alabama, California, Colorado, Illinois, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hepatitis C

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.